| Dr Erin Bee Jewell, PHARMD, RPH | |
|
1041 Main St, Longmont, CO 80501-4302 | |
| (303) 772-1111 | |
| Not Available |
| Full Name | Dr Erin Bee Jewell |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 1041 Main St, Longmont, Colorado |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174857973 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 3256 (Wyoming) | Secondary |
| 183500000X | Pharmacist | 18034 (Colorado) | Primary |
| 183500000X | Pharmacist | 19690 (North Carolina) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Erin Bee Jewell, PHARMD, RPH 1041 Main St, Longmont, CO 80501-4302 Ph: (303) 772-1111 | Dr Erin Bee Jewell, PHARMD, RPH 1041 Main St, Longmont, CO 80501-4302 Ph: (303) 772-1111 |
News Archive
The Liverpool School of Tropical Medicine has been awarded £11.8 million by the UK government's Global Challenges Research Fund for a grant to help improve the health of people living in informal settlements in low and middle-income countries.
Injury to peripheral nerves (the causes of which include shingles, HIV-AIDS, toxins, alcoholism, repetitive motion disorders, surgery, and cancer) causes neuropathic pain, which differs from ordinary pain and is usually perceived as a steady burning, pins and needles, electric shock sensations, and/or tickling.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that an acute migraine therapy that is not contraindicated in patients with a history, symptoms or signs of vascular disease and also offers improved efficacy and fast-acting oral delivery would earn a 45 percent patient share in the treatment of migraine, according to surveyed U.S. neurologists.
Esperion Therapeutics, a privately held biotechnology company working to discover, develop and commercialize treatments for cardiovascular and metabolic diseases, today announced the results from a Phase 1 study and four preclinical studies for ETC-1002 at the Arteriosclerosis, Thrombosis and Vascular Biology 2011 Scientific Sessions in Chicago.
Saint Louis University researchers have found that a type of compound that disrupts the process that causes fibrosis (scarring) in the lungs and liver also shows promise in preventing and treating fibrosis in yet another organ, the pancreas. The research was conducted in an animal model.
› Verified 3 days ago
Mary Kron, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1041 Main St, Longmont, CO 80501 Phone: 303-772-1111 Fax: 303-772-4247 | |
Dr. Kimberley Ann Mccoll, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 450 Ken Pratt Blvd, Longmont, CO 80501 Phone: 303-532-3488 | |
Cory Butler, PHARM. D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1041 N Main St, Longmont, CO 80501 Phone: 303-772-1111 Fax: 303-772-4247 | |
Sonja Marie Feero, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2255 Main St, Longmont, CO 80501 Phone: 303-772-7552 | |
Guy C Hertfelder, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 835 E 17th Ave, Longmont, CO 80504 Phone: 303-651-7468 | |
Mr. Rex Stephen Lynd, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 835 E 17th Ave, Longmont, CO 80504 Phone: 303-651-7468 Fax: 303-651-7845 | |
Jane Elizabeth Obradovich, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1050 Ken Pratt Blvd, Longmont, CO 80501 Phone: 303-682-0598 |